表位
免疫原性
主要组织相容性复合体
化学
人类白细胞抗原
肽
T细胞受体
抗原
氨基酸
肽序列
MHC I级
生物化学
残留物(化学)
分子生物学
生物
免疫系统
免疫学
基因
T细胞
作者
Gilles Guichard,ANNETTE C. ZERBIB,Frédérique‐Anne Le Gal,Johan Hoebeke,Francine Connan,Jeannine Choppin,Jean‐Paul Briand,Jean‐Gérard Guillet
摘要
The design of heteroclytic antigens with high MHC binding capacity is of particular interest to overcome the weak immunogenicity of peptide epitopes derived from tissue antigens expressed by tumors. In the present study, double-substituted peptide analogues of the tumor-associated antigen MART-1(27-35) incorporating a substitution at a primary anchor residue and a beta-amino acid residue at different positions in the sequence were synthesized and evaluated for binding to the human histocompatibility class I molecule HLA-A2 and for recognition by tumor-infiltrating lymphocytes. Interestingly, by combining a Leu for Ala substitution at P2 (which alone is deleterious for antigenic activity) with a beta-amino acid substitution at a putative TCR contact residue, recognition by tumor-infiltrating lymphocytes was partially restored. The analogue [Leu(28),beta-HIle(30)]MART-1(27-35) displays both a higher affinity to HLA-A2 and a more prolonged complex stability compared to [Leu(28)]MART-1(27-35). Overall, these results suggest that double-substitution strategies and beta-amino acid replacements at putative TCR contact residues might prove useful for the design of epitope mimics with high MHC binding capacity.
科研通智能强力驱动
Strongly Powered by AbleSci AI